Six months after the US Food and Drug Administration required cholesterol-lowering statin drugs to carry warnings about diabetes risks, Brigham and Women’s Hospital researchers conclude in a new analysis of a landmark study that the increased likelihood of diabetes is outweighed by the drugs’ protective effects against heart attacks, strokes and heart disease deaths. Paul Ridker, the Eugene Braunwald Professor of Medicine at Brigham and Women’s Hospital, is the leader of the study. Allison Goldfine, HMS associate professor of medicine at Joslin Diabetes Center, is also quoted.
